The Instituto de Salud Carlos III funds two new research projects in Lleida on multiple sclerosis and COVID-19 and to identify potential drugs directed against a key protein for entry of the SARS-CoV2 virus

It has also granted funding for two projects with IRBLleida researchers participation: Ferran Barbé, Jesús Caballero, Jose Manuel Valdivielso and Serafín Cambray

The Head of the Neurology section of the HUAV, Luis Brieva, leads the research on multiple sclerosis and the COVID-19 in collaboration with the Germanos Trias y Pujol de Badalona Hospital